Twist Bioscience Future Growth
Future criteria checks 1/6
Twist Bioscience is forecast to grow earnings and revenue by 35% and 14.7% per annum respectively. EPS is expected to grow by 39.7% per annum. Return on equity is forecast to be -14.1% in 3 years.
Key information
35.0%
Earnings growth rate
39.7%
EPS growth rate
| Biotechs earnings growth | 28.4% |
| Revenue growth rate | 14.7% |
| Future return on equity | -14.1% |
| Analyst coverage | Good |
| Last updated | 19 Nov 2024 |
Recent future growth updates
Recent updates
Twist Bioscience: A Post-Earnings Assessment
Nov 18Twist Bioscience's Earnings Preview: Partnerships And Valuation Make It A 'Buy'
Nov 08Twist Bioscience (NASDAQ:TWST) Is In A Strong Position To Grow Its Business
Sep 25
Investors Aren't Buying Twist Bioscience Corporation's (NASDAQ:TWST) Revenues
Aug 20Twist Bioscience: Lowered Biopharma Expectations Amid Financial Strain (Rating Downgrade)
Aug 04Twist Bioscience: Growing Customer Base And Technology Platform Make Me Like This Stock
Jul 26We Think Twist Bioscience (NASDAQ:TWST) Can Easily Afford To Drive Business Growth
Jun 10Twist Bioscience Corporation (NASDAQ:TWST) Shares Fly 29% But Investors Aren't Buying For Growth
May 04Twist Bioscience: NGS Is Taking Off
May 03Twist Bioscience Corporation (NASDAQ:TWST) Surges 26% Yet Its Low P/S Is No Reason For Excitement
Feb 27Twist Bioscience: Strong Performance In A Soft Market
Feb 07Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet
Jan 31We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate
Jan 22Twist Bioscience Corporation's (NASDAQ:TWST) Price Is Right But Growth Is Lacking After Shares Rocket 44%
Dec 18Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans
Oct 05We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth
Jul 07Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2027 | 519 | -73 | 5 | 40 | 5 |
| 9/30/2026 | 439 | -113 | -38 | 2 | 10 |
| 9/30/2025 | 373 | -147 | -56 | -51 | 10 |
| 9/30/2024 | 313 | -209 | -69 | -64 | N/A |
| 6/30/2024 | 295 | -220 | -75 | -69 | N/A |
| 3/31/2024 | 277 | -192 | -96 | -87 | N/A |
| 12/31/2023 | 262 | -206 | -129 | -111 | N/A |
| 9/30/2023 | 245 | -205 | -170 | -142 | N/A |
| 6/30/2023 | 235 | -209 | -165 | -123 | N/A |
| 3/31/2023 | 228 | -213 | -212 | -134 | N/A |
| 12/31/2022 | 216 | -214 | -233 | -132 | N/A |
| 9/30/2022 | 204 | -218 | -226 | -124 | N/A |
| 6/30/2022 | 184 | -208 | -251 | -158 | N/A |
| 3/31/2022 | 163 | -188 | -212 | -152 | N/A |
| 12/31/2021 | 146 | -165 | -170 | -134 | N/A |
| 9/30/2021 | 132 | -152 | -139 | -112 | N/A |
| 6/30/2021 | 127 | -135 | -124 | -103 | N/A |
| 3/31/2021 | 113 | -123 | -115 | -98 | N/A |
| 12/31/2020 | 101 | -117 | -144 | -132 | N/A |
| 9/30/2020 | 90 | -140 | -152 | -142 | N/A |
| 6/30/2020 | 73 | -147 | -152 | -140 | N/A |
| 3/31/2020 | 66 | -147 | -153 | -139 | N/A |
| 12/31/2019 | 60 | -141 | -116 | -101 | N/A |
| 9/30/2019 | 54 | -108 | -103 | -88 | N/A |
| 6/30/2019 | 47 | -96 | -93 | -81 | N/A |
| 3/31/2019 | 40 | -86 | -84 | -76 | N/A |
| 12/31/2018 | 33 | -77 | -76 | -72 | N/A |
| 9/30/2018 | 25 | -71 | -70 | -66 | N/A |
| 6/30/2018 | 20 | -68 | N/A | -61 | N/A |
| 9/30/2017 | 11 | -59 | N/A | -51 | N/A |
| 9/30/2016 | 2 | -44 | N/A | -39 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TWST is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TWST is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TWST is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TWST's revenue (14.7% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: TWST's revenue (14.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TWST is forecast to be unprofitable in 3 years.